Putting Wal-Mart Stores v. Dukes to the Test: Can This Class Be Certified?

• » Post Dukes Cases
• » In the Wake of Wal-Mart Stores v. Dukes, Where Are the Districts Headed on Class Certification?
• » Assessing Expert Testimony at Class Certification
  



Two Decades of Daubert: Junk Science Replaced by Junk Rulings?

• » Daubert and Other Gatekeeping Challenges with appendix_Antitrust
• » Daubert Turning 20 Updated

• » The New Class Action Landscape: A Trail Map to Class Certification and Practice in the Era After Wal-Mart and Concepcion
• » An Empirical Study of Class Action Settlements and Their Fee Awards
• » New Pleading Themes Under CAFA
• » Is It CAFA or Kafka?
• » "How Do You Take Your Multi-State, Class-Action Litigation? One Lump or Two?" Infusing State Class-Action Jurisprudence into Federal, Multi-State, Class-Certification Analyses in a "CAFA-Nated" World
• » "Twas Three Years after Twombly and All Through the Bar, Not a Plaintiff Was Troubled from Near or from Far"—The Unremarkable Effect of the U.S. Supreme Court's Re-Expressed Pleading Standard in Bell Atlantic Corp. v. Twombly
• » Defending the Class Action: Best Practices for Trial
• » Extracts of In Re Scrap Metal Antitrust Litigation Trial Transcript
• » Motion No.1: To Exclude Argument and Evidence Concerning Absent Class Members
• » Plaintiffs' Opposition to Defendants' Motion In Limine No.1 to Exclude Argument and Evidence Concerning Absent Class Members
• » Jury Verdict: Special Interrogatories
• » Plaintiff's (Post-Trial) Points for Charge: Submitted December 14, 2007
• » Amy Velez, et al v. Novalttis Pharmaceuticals Corporation Opening Remarks
• » Amy Velez, et al v. Novalttis Pharmaceuticals Corporation Closing Remarks
• » Amy Velez, et al v. Novalttis Pharmaceuticals Corporation More Closing Remarks
• » Plaintiffs' Proposed Jury Instructions and Verdict Form
• » Plaintiffs' Brief on Trial Management Plan
• » "It's Not Just Healthcare, the American Class Action Legal System Is Equally in Need of Reform": Yet Another Dysfunctional System Where the Cure Is Worse than the Disease
• » Cy Pres Settlements
• » Keeping the Flies Out of the Ointment: Restricting Objectors to Class Action Settlements
• » The End of Objector Blackmail?
• » "Open for Business: The Impact of the CFPB on Small Business"
• » Testimony of Daniel Fleming
• » Testimony of Dan Sokolov
• » Testimony of U.S. Chamber of Commerce
• » Building the CFPB: A Progress Report
• » CRS Summary
• » Full Text of HR 4173
• » Interim Rules on Alternative Mortgage Transaction Parity
• » Interim Rules of Practice
• » Interim Rules Relating to Disclosure of Records
• » Interim Rules Relating to Investigations
• » Interim State Notification Rules
• » Decisions Citing Wal-Mart v. Dukes: June–August 2011
• » The Impact of Wal-Mart Stores, Inc., v. Dukes, 131 S. Ct. 2541 (2011)
• » Brief For Petitioner
• » Reply Brief For Petitioner
• » Opinion in AT&T Mobility LLC, Petitioner, v. Vincent Concepcion
• » McKenzie Check Advance v. Wendy Betts, Donna Reuter Brief
• » Cruz v. Cingular Wireless
• » Litman v. Cellco Partnership
• » Quevedo v. Macys
• » GR Homa v. American Express Company

• » Multi-Jurisdictional, Cross-Border, and International Class Actions: Where Are We Heading?
  John P. Brown

• » Hot Topics in Class Actions: A Landmark Year
  Jaime Bianchi
  Jocelyn Larkin

• » Class Certification
  Prof. Linda S. Mullenix
• » Developments in Recent Class Certification Decisions: Are Courts Moving Towards Using Full Daubert Analysis for Class Certification Experts?
  Cari Dawson
• » Consumer Arbitration: The Picture Is Less Clear
  Martin C. Bryce, Jr.
• » Navigating Through a Sea of Documents: How Model Rule of Professional Conduct 4.4(b), Federal Rule of Evidence 502 and Federal Rule of Civil Procedure 26(b)(5) Will Impact the Way We Litigate and Try Cases
  Betsy P. Collins
  John H. Goselin II